138 is the total number of securities SECTOR GAMMA AS has owned. The longest SECTOR GAMMA AS has owned a single stock is 40 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
BSX | BOSTON SCIENTIFIC CORP | 40 | 40 | 1.97% | 6.31% | 9.94% | Q2 2013 | Q1 2023 | 40 |
BIO | BIO RAD LABS INC | 40 | 40 | 1.21% | 2.87% | 4.74% | Q2 2013 | Q1 2023 | 40 |
BMY | BRISTOL-MYERS SQUIBB CO | 38 | 38 | 1.26% | 6.27% | 11.88% | Q2 2014 | Q3 2023 | 38 |
BAX | BAXTER INTL INC | 26 | 3 | 1.64% | 7.05% | 12.74% | Q2 2013 | Q3 2023 | 34 |
CAH | CARDINAL HEALTH INC | 23 | 11 | 1.02% | 3.82% | 8.14% | Q2 2013 | Q3 2023 | 34 |
PKI | PERKINELMER INC | 33 | 33 | 1.85% | 4.66% | 6.25% | Q2 2013 | Q2 2021 | 33 |
BIIB | BIOGEN INC | 21 | 1 | 1.51% | 4.10% | 7.58% | Q4 2013 | Q3 2023 | 30 |
ANTM | ELEVANCE HEALTH INC | 30 | 30 | 1.80% | 3.77% | 5.60% | Q2 2016 | Q3 2023 | 30 |
GILD | GILEAD SCIENCES INC | 29 | 29 | 1.41% | 6.66% | 14.04% | Q3 2016 | Q3 2023 | 29 |
THC | TENET HEALTHCARE CORP | 19 | 4 | 0.50% | 1.84% | 4.33% | Q4 2013 | Q3 2023 | 28 |
PDCO | PATTERSON COS INC | 18 | 4 | 0.76% | 1.98% | 3.79% | Q1 2014 | Q1 2022 | 26 |
LLY | LILLY ELI & CO | 22 | 2 | 0.23% | 7.82% | 13.68% | Q2 2013 | Q4 2019 | 24 |
MRK | MERCK & CO INC NEW | 14 | 4 | 1.45% | 6.21% | 12.18% | Q1 2016 | Q1 2023 | 24 |
NUVA | NUVASIVE INC | 24 | 24 | 1.55% | 3.34% | 5.01% | Q3 2017 | Q2 2023 | 24 |
IONS | IONIS PHARMACEUTICALS INC | 24 | 24 | 0.52% | 2.01% | 3.74% | Q4 2017 | Q3 2023 | 24 |
INCY | INCYTE CORP | 21 | 21 | 2.32% | 5.54% | 7.81% | Q3 2018 | Q3 2023 | 21 |
ABT | ABBOTT LABS | 19 | 1 | 1.20% | 7.83% | 11.94% | Q2 2016 | Q2 2022 | 20 |
IRWD | IRONWOOD PHARMACEUTICA... | 20 | 20 | 1.28% | 4.06% | 5.88% | Q3 2013 | Q2 2018 | 20 |
IART | INTEGRA LIFESCIENCES H... | 20 | 20 | 0.91% | 3.23% | 4.99% | Q4 2013 | Q3 2018 | 20 |
BRKR | BRUKER CORP | 18 | 18 | 1.65% | 3.01% | 4.45% | Q2 2019 | Q3 2023 | 18 |
PRGO | PERRIGO CO PLC | 18 | 18 | 1.43% | 2.56% | 3.66% | Q1 2017 | Q2 2021 | 18 |
ALNY | ALNYLAM PHARMACEUTICAL... | 6 | 1 | 0.20% | 1.12% | 2.40% | Q4 2017 | Q3 2023 | 18 |
VRTX | VERTEX PHARMACEUTICALS... | 11 | 2 | 1.40% | 2.94% | 4.64% | Q2 2013 | Q2 2022 | 16 |
CVS | CVS HEALTH CORP | 13 | 3 | 0.69% | 2.61% | 5.00% | Q4 2018 | Q1 2023 | 16 |
LH | LABORATORY CORP AMER H... | 6 | 4 | 1.54% | 2.56% | 4.53% | Q1 2017 | Q3 2023 | 16 |
RARE | ULTRAGENYX PHARMACEUTI... | 9 | 7 | 0.06% | 0.88% | 1.76% | Q2 2018 | Q3 2023 | 16 |
JNJ | JOHNSON & JOHNSON | 7 | 1 | 0.88% | 4.38% | 10.62% | Q2 2013 | Q2 2023 | 15 |
CI | CIGNA CORPORATION | 15 | 15 | 0.87% | 2.31% | 3.38% | Q2 2014 | Q4 2017 | 15 |
QGEN | QIAGEN NV | 10 | 5 | 1.04% | 2.31% | 3.40% | Q4 2018 | Q3 2023 | 15 |
UHS | UNIVERSAL HLTH SVCS INC | 8 | 7 | 0.54% | 1.33% | 2.10% | Q1 2018 | Q3 2022 | 15 |
MNTA | MOMENTA PHARMACEUTICAL... | 12 | 3 | 0.64% | 1.27% | 2.42% | Q2 2013 | Q4 2017 | 15 |
MDT | MEDTRONIC PLC | 14 | 14 | 4.60% | 5.57% | 7.57% | Q2 2020 | Q3 2023 | 14 |
A | AGILENT TECHNOLOGIES INC | 9 | 5 | 1.85% | 3.34% | 4.37% | Q2 2013 | Q3 2020 | 14 |
MASI | MASIMO CORP | 11 | 3 | 1.65% | 2.87% | 3.97% | Q2 2013 | Q2 2017 | 14 |
SPPI | SPECTRUM PHARMACEUTICA... | 14 | 14 | 0.05% | 0.11% | 0.13% | Q2 2013 | Q3 2016 | 14 |
SHPG | SHIRE PLC | 12 | 1 | 1.66% | 4.10% | 5.83% | Q2 2013 | Q4 2018 | 13 |
BMRN | BIOMARIN PHARMACEUTICA... | 8 | 2 | 1.01% | 2.25% | 3.69% | Q4 2019 | Q3 2023 | 13 |
ELAN | ELANCO ANIMAL HEALTH INC | 13 | 13 | 1.00% | 1.90% | 2.61% | Q1 2019 | Q1 2022 | 13 |
OMI | OWENS & MINOR INC NEW | 10 | 3 | 0.78% | 1.50% | 3.09% | Q2 2013 | Q3 2017 | 13 |
CLVS | CLOVIS ONCOLOGY INC | 13 | 13 | 0.21% | 0.97% | 1.86% | Q3 2017 | Q3 2020 | 13 |
CNC | CENTENE CORP DEL | 12 | 12 | 2.22% | 3.44% | 4.08% | Q4 2020 | Q3 2023 | 12 |
LPNT | LIFEPOINT HOSPITALS INC | 8 | 4 | 1.46% | 2.40% | 3.56% | Q2 2013 | Q2 2017 | 12 |
MCK | MCKESSON CORP | 9 | 3 | 0.93% | 2.20% | 3.10% | Q4 2015 | Q2 2019 | 12 |
UTHR | UNITED THERAPEUTICS CO... | 5 | 3 | 0.62% | 1.55% | 3.29% | Q2 2013 | Q1 2020 | 12 |
PTCT | PTC THERAPEUTICS INC | 6 | 6 | 0.52% | 0.87% | 1.66% | Q1 2019 | Q2 2023 | 12 |
EW | EDWARDS LIFESCIENCES CORP | 7 | 4 | 2.97% | 4.29% | 6.10% | Q3 2013 | Q3 2023 | 11 |
MDCO | MEDICINES CO | 10 | 10 | 0.81% | 1.96% | 3.29% | Q2 2013 | Q3 2015 | 10 |
TEVA | TEVA PHARMACEUTICAL IN... | 9 | 9 | 2.00% | 3.56% | 4.94% | Q2 2013 | Q2 2015 | 9 |
THOR | THORATEC CORP | 9 | 9 | 1.83% | 2.97% | 4.60% | Q2 2013 | Q2 2015 | 9 |
ALXN | ALEXION PHARMACEUTICAL... | 7 | 1 | 0.71% | 2.68% | 5.60% | Q4 2016 | Q1 2021 | 9 |
DGX | QUEST DIAGNOSTICS INC | 6 | 3 | 1.29% | 2.68% | 3.96% | Q4 2013 | Q2 2020 | 9 |
WCG | WELLCARE HEALTH PLANS INC | 7 | 1 | 1.76% | 2.40% | 3.16% | Q3 2013 | Q1 2016 | 9 |
LXRX | LEXICON PHARMACEUTICAL... | 9 | 9 | 0.34% | 1.20% | 1.72% | Q1 2017 | Q1 2019 | 9 |
RIGL | RIGEL PHARMACEUTICALS INC | 9 | 9 | 0.37% | 0.89% | 1.31% | Q3 2020 | Q3 2022 | 9 |
PTLA | PORTOLA PHARMACEUTICAL... | 9 | 9 | 0.41% | 0.88% | 1.42% | Q4 2017 | Q4 2019 | 9 |
BDX | BECTON DICKINSON & CO | 6 | 2 | 1.52% | 4.33% | 5.80% | Q4 2020 | Q3 2023 | 8 |
VIR | VIR BIOTECHNOLOGY INC | 8 | 8 | 0.36% | 0.56% | 0.83% | Q4 2021 | Q3 2023 | 8 |
SGMO | SANGAMO THERAPEUTICS INC | 8 | 8 | 0.28% | 0.36% | 0.44% | Q1 2018 | Q4 2019 | 8 |
PFE | PFIZER INC | 7 | 7 | 1.17% | 4.76% | 9.06% | Q4 2020 | Q2 2022 | 7 |
ZBH | ZIMMER BIOMET HOLDINGS... | 7 | 7 | 1.80% | 4.13% | 5.52% | Q1 2022 | Q3 2023 | 7 |
NVAX | NOVAVAX INC | 6 | 1 | 0.24% | 0.45% | 0.64% | Q4 2020 | Q3 2022 | 7 |
AZN | ASTRAZENECA PLC | 5 | 1 | 1.14% | 3.62% | 5.23% | Q3 2017 | Q1 2022 | 6 |
CBST | CUBIST PHARMACEUTICALS... | 6 | 6 | 2.92% | 3.31% | 4.08% | Q2 2013 | Q3 2014 | 6 |
RMD | RESMED INC | 5 | 1 | 1.80% | 2.27% | 2.99% | Q2 2013 | Q4 2014 | 6 |
AUXL | AUXILIUM PHARMACEUTICA... | 6 | 6 | 0.60% | 2.12% | 3.56% | Q2 2013 | Q3 2014 | 6 |
REGN | REGENERON PHARMACEUTICALS | 3 | 1 | 0.42% | 1.78% | 3.55% | Q2 2018 | Q2 2021 | 6 |
CYH | COMMUNITY HEALTH SYS INC | 6 | 6 | 1.25% | 1.74% | 2.57% | Q3 2014 | Q4 2015 | 6 |
LIVN | LIVANOVA PLC | 6 | 6 | 0.22% | 1.32% | 2.54% | Q1 2020 | Q2 2021 | 6 |
IPXL | IMPAX LABORATORIES INC | 6 | 6 | 1.08% | 1.26% | 1.38% | Q2 2016 | Q3 2017 | 6 |
SAGE | SAGE THERAPEUTICS INC | 6 | 6 | 0.85% | 0.96% | 1.17% | Q2 2021 | Q3 2022 | 6 |
SYK | STRYKER CORP | 5 | 5 | 2.47% | 4.83% | 6.38% | Q3 2014 | Q3 2015 | 5 |
OGN | ORGANON & CO | 5 | 5 | 2.58% | 2.98% | 3.57% | Q2 2021 | Q2 2022 | 5 |
CI | CIGNA CORP NEW | 5 | 5 | 1.69% | 2.90% | 3.91% | Q4 2021 | Q4 2022 | 5 |
HUM | HUMANA INC | 5 | 5 | 1.90% | 2.66% | 2.99% | Q2 2019 | Q2 2020 | 5 |
HSP | HOSPIRA INC | 3 | 2 | 0.76% | 2.49% | 3.87% | Q2 2013 | Q4 2014 | 5 |
UNH | UNITEDHEALTH GROUP INC | 5 | 5 | 0.52% | 1.72% | 2.88% | Q2 2013 | Q2 2014 | 5 |
ACOR | ACORDA THERAPEUTICS INC | 5 | 5 | 0.77% | 1.67% | 2.99% | Q4 2013 | Q4 2014 | 5 |
AGIO | AGIOS PHARMACEUTICALS INC | 4 | 1 | 0.49% | 0.62% | 0.82% | Q1 2018 | Q4 2019 | 5 |
STJ | ST JUDE MED INC | 3 | 1 | 1.77% | 3.19% | 5.36% | Q4 2013 | Q2 2016 | 4 |
SGEN | SEAGEN INC | 4 | 4 | 1.77% | 2.47% | 3.12% | Q2 2022 | Q1 2023 | 4 |
ESRX | EXPRESS SCRIPTS INC | 4 | 4 | 1.56% | 2.08% | 2.78% | Q2 2013 | Q1 2014 | 4 |
RAD | RITE AID CORP | 4 | 4 | 1.78% | 2.02% | 2.27% | Q4 2014 | Q3 2015 | 4 |
CTLT | CATALENT INC | 4 | 4 | 0.57% | 1.78% | 2.41% | Q4 2022 | Q3 2023 | 4 |
ABC | AMERISOURCEBERGEN CORP | 4 | 4 | 1.36% | 1.78% | 2.26% | Q2 2014 | Q1 2015 | 4 |
TAK | TAKEDA PHARMACEUTICAL ... | 4 | 4 | 0.10% | 1.71% | 2.37% | Q1 2019 | Q4 2019 | 4 |
HCA | HCA HEALTHCARE INC | 4 | 4 | 0.71% | 1.40% | 2.01% | Q2 2020 | Q1 2021 | 4 |
AGN | ALLERGAN INC | 3 | 1 | 0.83% | 1.20% | 1.58% | Q2 2013 | Q3 2014 | 4 |
RDY | DR REDDYS LABS LTD | 3 | 1 | 0.57% | 1.02% | 1.49% | Q2 2014 | Q1 2019 | 4 |
ACAD | ACADIA PHARMACEUTICALS... | 4 | 4 | 0.68% | 0.94% | 1.08% | Q4 2022 | Q3 2023 | 4 |
BNTX | BIONTECH SE | 2 | 1 | 0.79% | 0.87% | 1.08% | Q1 2021 | Q1 2023 | 4 |
ONCE | SPARK THERAPEUTICS INC | 4 | 4 | 0.29% | 0.43% | 0.56% | Q4 2017 | Q3 2018 | 4 |
FRX | FOREST LABS INC | 3 | 3 | 7.13% | 8.92% | 10.79% | Q2 2013 | Q4 2013 | 3 |
BXLT | BAXALTA INC | 3 | 3 | 2.96% | 6.59% | 9.19% | Q3 2015 | Q1 2016 | 3 |
EXEL | EXELIXIS INC | 3 | 3 | 1.46% | 2.67% | 3.48% | Q2 2016 | Q4 2016 | 3 |
ILMN | ILLUMINA INC | 2 | 1 | 1.34% | 2.13% | 2.86% | Q2 2013 | Q1 2023 | 3 |
MYL | MYLAN N V | 2 | 1 | 0.93% | 2.02% | 3.59% | Q4 2017 | Q2 2019 | 3 |
5100PS | VOLCANO CORPORATION | 1 | 1 | 1.39% | 1.85% | 2.25% | Q3 2013 | Q3 2014 | 3 |
AGN | ALLERGAN PLC | 2 | 1 | 1.57% | 1.75% | 1.95% | Q4 2017 | Q4 2018 | 3 |
XRAY | DENTSPLY SIRONA INC | 3 | 3 | 0.59% | 1.67% | 2.91% | Q3 2021 | Q1 2022 | 3 |
CTRX | CATAMARAN CORP | 3 | 3 | 0.64% | 0.98% | 1.19% | Q1 2014 | Q3 2014 | 3 |
ITCI | INTRA-CELLULAR THERAPI... | 3 | 3 | 0.82% | 0.98% | 1.08% | Q1 2022 | Q3 2022 | 3 |
MRTX | MIRATI THERAPEUTICS INC | 3 | 3 | 0.21% | 0.68% | 0.92% | Q3 2021 | Q1 2022 | 3 |
BLUE | BLUEBIRD BIO INC | 2 | 1 | 0.44% | 0.60% | 0.88% | Q2 2018 | Q1 2020 | 3 |
ABBV | ABBVIE INC | 2 | 2 | 3.05% | 4.26% | 5.46% | Q1 2014 | Q2 2014 | 2 |
GE HEALTHCARE TECHNOLO... | 2 | 2 | 2.75% | 3.37% | 3.99% | Q2 2023 | Q3 2023 | 2 | |
ONXX | ONYX PHARMACEUTICALS INC | 2 | 2 | 3.29% | 3.29% | 3.30% | Q2 2013 | Q3 2013 | 2 |
MDVN | MEDIVATION INC | 2 | 2 | 2.07% | 2.86% | 3.65% | Q4 2015 | Q1 2016 | 2 |
SLXP | SALIX PHARMACEUTICALS INC | 2 | 2 | 2.42% | 2.63% | 2.84% | Q2 2013 | Q3 2013 | 2 |
OPTR | OPTIMER PHARMACEUTICAL... | 2 | 2 | 1.22% | 1.33% | 1.44% | Q2 2013 | Q3 2013 | 2 |
GSK | GLAXOSMITHKLINE PLC | 2 | 2 | 0.85% | 1.24% | 1.63% | Q3 2017 | Q4 2017 | 2 |
AMED | AMEDISYS INC | 2 | 2 | 0.59% | 1.02% | 1.45% | Q2 2023 | Q3 2023 | 2 |
LNTH | LANTHEUS HLDGS INC | 2 | 2 | 0.90% | 0.92% | 0.94% | Q2 2023 | Q3 2023 | 2 |
CERN | CERNER CORP | 2 | 2 | 0.43% | 0.82% | 1.21% | Q2 2020 | Q3 2020 | 2 |
AVNR | AVANIR PHARMACEUTICALS... | 2 | 2 | 0.64% | 0.77% | 0.89% | Q2 2014 | Q3 2014 | 2 |
ARRY | ARRAY BIOPHARMA INC | 2 | 2 | 0.58% | 0.69% | 0.80% | Q3 2018 | Q4 2018 | 2 |
QTRX | QUANTERIX CORP | 2 | 2 | 0.32% | 0.44% | 0.56% | Q1 2022 | Q2 2022 | 2 |
SOMALOGIC INC | 2 | 2 | 0.30% | 0.42% | 0.52% | Q1 2022 | Q2 2022 | 2 | |
RDUS | RADIUS HEALTH INC | 2 | 2 | 0.23% | 0.25% | 0.28% | Q3 2017 | Q4 2017 | 2 |
ATRA | ATARA BIOTHERAPEUTICS INC | 2 | 2 | 0.22% | 0.23% | 0.25% | Q1 2022 | Q2 2022 | 2 |
EMBECTA CORP | 2 | 2 | 0.03% | 0.03% | 0.04% | Q2 2022 | Q3 2022 | 2 | |
MYL | MYLAN INC | 1 | 1 | 3.22% | 3.22% | 3.22% | Q4 2014 | Q4 2014 | 1 |
CELG | CELGENE CORP | 1 | 1 | 2.83% | 2.83% | 2.83% | Q4 2018 | Q4 2018 | 1 |
GMED | GLOBUS MED INC | 1 | 1 | 2.82% | 2.82% | 2.82% | Q3 2023 | Q3 2023 | 1 |
HSIC | HENRY SCHEIN INC | 1 | 1 | 2.18% | 2.18% | 2.18% | Q2 2021 | Q2 2021 | 1 |
MNKKQ | MALLINCKRODT PUB LTD CO | 1 | 1 | 2.02% | 2.02% | 2.02% | Q3 2013 | Q3 2013 | 1 |
HOLX | HOLOGIC INC | 1 | 1 | 1.39% | 1.39% | 1.39% | Q2 2021 | Q2 2021 | 1 |
HNT | HEALTH NET INC | 1 | 1 | 1.16% | 1.16% | 1.16% | Q4 2013 | Q4 2013 | 1 |
DVA | DAVITA INC | 1 | 1 | 1.05% | 1.05% | 1.05% | Q4 2017 | Q4 2017 | 1 |
SRCL | STERICYCLE INC | 1 | 1 | 0.94% | 0.94% | 0.94% | Q4 2017 | Q4 2017 | 1 |
KENVUE INC | 1 | 1 | 0.74% | 0.74% | 0.74% | Q3 2023 | Q3 2023 | 1 | |
SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 0.68% | 0.68% | 0.68% | Q1 2018 | Q1 2018 | 1 |
AUPH | AURINIA PHARMACEUTICAL... | 1 | 1 | 0.54% | 0.54% | 0.54% | Q2 2021 | Q2 2021 | 1 |
CVAC | CUREVAC N V | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2021 | Q1 2021 | 1 |
DNDNQ | DENDREON CORP | 1 | 1 | 0.41% | 0.41% | 0.41% | Q2 2013 | Q2 2013 | 1 |
JUNO | JUNO THERAPEUTICS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q4 2017 | Q4 2017 | 1 |
TMO | THERMO FISHER SCIENTIF... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2013 | Q2 2013 | 1 |
RGNX | REGENXBIO INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2018 | Q2 2018 | 1 |
VVUS | VIVUS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2014 | Q1 2014 | 1 |
Download |
The securities at the top of the list , including BOSTON SCIENTIFIC CORP, BIO RAD LABS INC, and BRISTOL-MYERS SQUIBB CO, are the highest-conviction holdings of SECTOR GAMMA AS.
The conviction is calculated by counting the number of quarters a security has been reported by SECTOR GAMMA AS. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that SECTOR GAMMA AS owns currently or has owned in the past.